Significance
Cystic fibrosis is a fatal disease caused by inherited defects in the cftr gene. The cystic fibrosis transmembrane conductance regulator (CFTR) protein is an epithelial anion channel and resolving the structure and function of CFTR is crucial for understanding how salt and fluid homeostasis is maintained across epithelial surfaces. As an ion channel evolved from a family of adenosine-5'-triphosphate (ATP)-driven active transporters, CFTR is structurally distinct from any other ion channel. This study describes the structure of a selectivity filter in CFTR, which enables us to complete the molecular description of the CFTR pore. Moreover, it enriches our broader knowledge of ion channel physiology, with a particular focus on chloride permeation mechanisms.
Keywords: selectivity filter, chloride channel, CFTR
Abstract
The cystic fibrosis transmembrane conductance regulator (CFTR) is a chloride channel that regulates transepithelial salt and fluid homeostasis. CFTR dysfunction leads to reduced chloride secretion into the mucosal lining of epithelial tissues, thereby causing the inherited disease cystic fibrosis. Although several structures of CFTR are available, our understanding of the ion-conduction pathway is incomplete. In particular, the route that connects the cytosolic vestibule with the extracellular space has not been clearly defined, and the structure of the open pore remains elusive. Furthermore, although many residues have been implicated in altering the selectivity of CFTR, the structure of the “selectivity filter” has yet to be determined. In this study, we identify a chloride-binding site at the extracellular ends of transmembrane helices 1, 6, and 8, where a dehydrated chloride is coordinated by residues G103, R334, F337, T338, and Y914. Alterations to this site, consistent with its function as a selectivity filter, affect ion selectivity, conductance, and open channel block. This selectivity filter is accessible from the cytosol through a large inner vestibule and opens to the extracellular solvent through a narrow portal. The identification of a chloride-binding site at the intra- and extracellular bridging point leads us to propose a complete conductance path that permits dehydrated chloride ions to traverse the lipid bilayer.
The cystic fibrosis transmembrane conductance regulator (CFTR), a phosphorylation- and adenosine-5'-triphosphate (ATP)-gated anion channel (1–6), functions to regulate salt and fluid homeostasis across epithelial membranes (7). Alterations to CFTR that interfere with expression, folding, or localization to the plasma membrane or the function of the mature channel cause reduced chloride and bicarbonate transport across the apical surface of epithelial tissues and lead to the autosomal recessive disorder cystic fibrosis (7–14). CFTR hyperactivation during infection with Vibrio cholerae or enterotoxigenic Escherichia coli leads to secretory diarrhea and is relevant to pathogenesis in autosomal dominant polycystic kidney disease (15–18). Extensive effort has been devoted to characterizing CFTR folding, gating, and ion conduction (19, 20) and to develop pharmacological modulators of these processes (21–27).
CFTR belongs to the ATP-binding cassette (ABC) transporter superfamily. Like other ABC transporters, CFTR consists of two nucleotide-binding domains (NBDs) and two transmembrane domains (TMDs) (19, 20). In addition, CFTR also contains a cytosolic regulatory domain bearing more than 10 predicted phosphorylation sites (28). Protein kinase A (PKA)-phosphorylation of the regulatory domain is necessary for channel activation (2–5). Once phosphorylated, ATP-dependent dimerization of the NBDs is coupled to movements of the TMDs that open the pore (1, 6, 29, 30). Hydrolysis of ATP in CFTR’s catalytically competent ATP-binding site leads to pore closure (6, 31).
Most ABC transporters are ATP-driven pumps that function via the alternating access model, in which a translocation pathway opens only to one side of the membrane at a time (32–34). In NBD-dimerized (outward-facing) structures of typical ABC transporters, the substrate binding site is occluded from exchange with the cytosol (35–37). By contrast, in the NBD-dimerized structure of CFTR, characterized using the hydrolysis-deficient E1371Q variant, the cytosol is continuous with an inner vestibule through a lateral portal between TMs 4 and 6 through which hydrated chloride can freely diffuse (29, 38–40). This structural feature renders CFTR an ion channel instead of an active transporter, as it encloses a continuous conduit across the membrane for chloride to permeate down its electrochemical gradient. The NBD-dimerized structures of CFTR were however initially interpreted to have a partially closed outer gate to thus occlude ion conduction (29).
Decades of mutagenesis studies have indicated that the pore in CFTR has an overall shape of a distorted hourglass, consisting of a shallow outer vestibule and a deep cytosolic vestibule, separated by a narrow constriction [reviewed by Linsdell (41)]. While the intracellular entrance (38, 39) and the cytosolic vestibule (42–46) of the pore were clearly defined in the published structures of CFTR (40, 47–49), the exact path of chloride from the inner vestibule to the extracellular space remains unclear. Extensive mapping by mutagenesis (50–53), cysteine accessibility (38, 54–56), and molecular dynamics (57) has also not allowed unambiguous assignment of the extracellular exit. Furthermore, although many residues have been shown to influence the conductance or relative permeabilities of different anions in CFTR (reviewed in refs. 19, 20, and 41), a specific selectivity filter has yet to be defined.
In this study, we analyzed the 2.7 Å cryo‐electron microscopy (cryo-EM) map of the E1371Q variant (48) and identified a chloride-binding site at the extracellular end of the pore, where a dehydrated chloride ion is coordinated by G103, R334, F337, T338, and Y914. Electrophysiological measurements indicate that this binding site functions as a selectivity filter, determining the relative permeabilities of different anions. This selectivity filter is accessible from the cytosol and connected to the extracellular space through a narrow portal between TMs 1 and 6. These data lead us to propose the complete ion permeation path in CFTR and suggest that the structure of the NBD-dimerized E1371Q variant reflects a pore-open state rather than a flicker-closed state.
Results
Identification of a Chloride-Binding Site at the Extracellular Tip of the Pore.
Previously, we have reported the structure of a CFTR variant with high open probability (E1371Q) bound to the type I folding corrector lumacaftor to a resolution of 2.7 Å (48). In this structure, the two NBDs have formed a canonical ATP-dependent dimer, which is coupled to isomerization in the TMDs necessary for pore opening (Fig. 1A). Mapping the dimensions of the channel using a spherical probe with a radius equal to a dehydrated chloride ion (1.7 Å) clearly identifies a solvent-accessible vestibule in which ions can diffuse from the cytosol to the extracellular surface of the membrane (Fig. 1A, blue surface). Close inspection of the 2.7 Å map revealed a strong density at the tip of this vestibule which likely corresponds to an ion (Fig. 1B). The density is observed in an area of the map with a high degree of completeness, and it appears at a higher contour than other densities attributed to map noise.
The putative ion density is surrounded by residues suitable for chloride coordination (58). The hydroxyls of T338 and Y914 engage in anion–dipole interactions with coordination lengths of 3.4 Å from Oγ1 of T338 and 3.8 Å from Oη of Y914 (Fig. 1B). The Nε of R334 is positioned 4.9 Å away to engage in a long-range salt bridge that may stabilize the negative charge of permeating anions. The aromatic side chain of F337 directs its electropositive edge toward the chloride, with Cδ 3.4 Å away to engage in an anion–quadrupole interaction (59). In addition, the alpha carbon of G103 is 3.6 Å away, which may further stabilize the bound ion. Because the most abundant anion in the cryo-EM sample is chloride (present at 200 mM), and because the coordination geometry is consistent with chloride (58), we assigned the density to a dehydrated chloride ion.
The most prominent path from the chloride-binding site to the extracellular milieu is through a narrow lateral exit within TMD1 between TMs 1 and 6, delimited by the side chains of R104, R334, K335, and T338 and the main chain of G103 (Fig. 1 C and D). The electropositive potential around the external region of the opening is consistent with it being an anion conduction pathway, stabilizing anions through electrostatic interactions. Previously, based on a lower-resolution structure obtained in the absence of lumacaftor, we proposed this opening to be the extracellular mouth of the pore (40). The identification of a bound chloride ion at its junction with the inner vestibule lends further support for this hypothesis. This exit path is unique among ABC transporters. In structures of all other outward-facing ABC exporters, the extracellular ends of the transmembrane helices splay apart to release substrate. Examples include Sav1866 (35), the P-glycoprotein (37), the multidrug resistance protein 1 (36), and TmrAB (60).
Residues that coordinate the chloride or line the extracellular mouth are highly conserved across CFTR orthologs (SI Appendix, Fig. S1A). By contrast, only F337 is conserved across human ABCC paralogues (SI Appendix, Fig. S1B). In transporters such as ABCC1, this phenylalanine residue plays a distinct role by forming part of the outer gate that occludes the substrate binding site from the extracellular space in inward-facing structures (61–63). Many of the residues at the chloride-binding site have been previously implicated in ion conduction or selectivity. These include the directly coordinating R334, F337, T338, and Y914 (64–70) and the residues L102, K335, and S341 located immediately proximal to the site (53, 65, 68, 71). Defective conductance has also been associated with the cystic fibrosis-causative R334W, R334L, and T338I missense mutations (14, 51, 72, 73). Combining these data with structural observations leads us to hypothesize that the observed site, termed Sfilter, corresponds to a selectivity filter that is transited by anions during conduction.
Altered Anion Permeabilities of Selectivity Filter Variants.
To further test the functional importance of Sfilter, we substituted the contributing residues individually and analyzed whether the properties of the pore were altered. Substitution of residues at the putative anion-binding site did not affect the expression or folding of CFTR, evident from the size-exclusion chromatography profiles of all tested variants, which closely resembled that of the wild-type CFTR (SI Appendix, Fig. S2). Nonetheless, we were unable to measure currents from G103D (7 trials), G103I (10 trials), and Y914A (23 trials) variants, potentially due to complete occlusion or distortion of the chloride permeation path.
For the Sfilter site variants from which currents were measurable, we first tested whether the site acts as a selectivity filter by measuring the effect of substitutions on relative anion permeabilities. Relative permeabilities of fluoride, chloride, bromide, iodide, and thiocyanate were estimated from reversal potentials in excised inside-out patches under biionic conditions using the Goldman–Hodgkin–Katz equation (74, 75) (Fig. 2 and SI Appendix, Fig. S3). In these experiments, inside-out patches were excised from Chinese Hamster Ovary (CHO) cells transiently transfected with the wild-type CFTR or Sfilter variants. CFTR was then activated by PKA-phosphorylation, currents elicited by ATP stimulation, and current–voltage relationships measured while perfusing different permeant anions onto the patch (Fig. 2A). As was previously reported (67, 76), and consistent with permeating anions having to dehydrate, wild-type CFTR exhibits a lyotropic permeability sequence, with relative permeabilities inversely related to the enthalpy of dehydration (77) (Fig. 2B). Upon R334A, F337A, T338A, or Y914F substitution, the relative anion permeabilities were all altered, albeit to different degrees, consistent with previous work (66–68) (Fig. 2 A and B). Specifically, the R334A substitution reduced the relative permeabilities for bromide and thiocyanate. The F337A substitution rendered CFTR much less discriminating against fluoride and substantially increased fluoride conductance. The T338A substitution only caused subtle changes, with an increased relative fluoride permeability being most prominent. T338A substitution also made the iodide and thiocyanate conductances more similar to chloride conductance than in the case of wild-type CFTR (Fig. 2A). Most relative permeabilities of the Y914F variant were similar to the wild-type CFTR, but the relative bromide permeability was subtly reduced. These data strongly support that the ion-binding site comprising R334, F337, T338, and Y914 functions as a selectivity filter, that contributes to determining the relative permeabilities of different anions.
Reduced Thiocyanate Block of Selectivity Filter Variants.
While thiocyanate is a permeant ion, it also binds more tightly to the CFTR pore than chloride and therefore inhibits chloride conductance (52, 66, 78). To test whether thiocyanate block occurs at Sfilter, we measured the effects of thiocyanate on the conductance of Sfilter variants (Fig. 3 and SI Appendix, Fig. S4). Specifically, we measured current–voltage relationships with different mole fractions of thiocyanate perfused onto inside-out patches excised from CHO cells expressing each of the selectivity filter variants (Fig. 3A). Thiocyanate block was quantified as the relative reduction of conduction at the reversal potential (Fig. 3B). As described in the literature (66), chloride currents measured from wild-type CFTR were substantially reduced even by low concentrations of thiocyanate (Fig. 3 A and B). Relative to the wild-type CFTR, the F337A, Y914F, R334A, and T338A variants all exhibited variable extents of reduced block by thiocyanate. The greatest effect was observed for the T338A variant which, consistent with a previous report (66), became largely insensitive to thiocyanate block. The reduced efficacies of thiocyanate block toward each of the tested variants are consistent with thiocyanate binding at the Sfilter site, competing with chloride with a greater affinity to thereby reduce conductance.
Altered Single-Channel Conductances of Selectivity Filter Variants.
We next tested the effects of substitutions at the Sfilter site on the single-channel conductances of CFTR. Each variant was purified, phosphorylated with PKA, and reconstituted into synthetic planar lipid bilayers. The current–voltage relationships were measured in 150 mM symmetric chloride (Fig. 4). Channel orientation was controlled by only including 3 mM ATP in the recording buffer of one of the two recording chambers and was validated by observing the voltage dependence of flicker-closure events (79) (Fig. 4A). Data were fitted with a parabola to account for the subtle inward rectification (Fig. 4B). Under these conditions, the conductance of the wild-type CFTR at 0 mV was 7.9 ± 0.2 pS (mean and SE). T388A substitution had little effect on single-channel conductance (8.2 ± 0.3 pS), consistent with a previous report (66). By contrast, the conductances of the three other variants were reduced to 5.7 ± 0.2 pS (Y914F), 5.0 ± 0.3 pS (F337A), and 3.0 ± 0.2 pS (R334A). These data indicate that disruption of interactions with the permeant ion at the Sfilter site increases the energetic barrier for transfer through the pore, underscoring the importance of the Sfilter site for anion conduction.
Discussion
CFTR is an ion channel uniquely evolved from a family of active transporters. Structurally, it resembles an ABC transporter unrelated to any other ion channels. The CFTR pore has been extensively mapped with mutagenesis (reviewed in refs. 19, 20, and 41) and partially visualized in the molecular structures of CFTR (40, 47–49). In this study, we identified a specific ion-binding site in the narrow constriction of the pore that influences ion selectivity; it also structurally connects the cytosolic vestibule with a lateral path into the extracellular space. With this information, we now have a structural understanding of the entire permeation pathway in CFTR (Fig. 5A). Hydrated chloride enters the inner vestibule from the cytosol through a lateral portal between TMs 4 and 6 (Fig. 5 B, Lower). Chloride remains hydrated in the inner vestibule and is stabilized by a positive electrostatic surface potential. The width of the vestibule tapers down and converges at a selectivity filter, where only dehydrated chloride can enter. Dehydrated chloride moves into this selectivity filter, stabilized by interactions with G103, R334, F337, T338, and Y914 and rehydrates upon exit into the epithelial lumen through a narrow lateral exit between TMs 1 and 6 (Fig. 5 B, Upper).
Previous mutational work has identified a plethora of residues, many are arginine and lysine, that influence CFTR ion selectivity and/or conductance (38, 56, 81–83). Mapping these residues onto the CFTR structure indicates that basic residues, including K95, R104, R117, K190, R248, R303, K335, R352, K370, K1041, and R1048 (Fig. 5A, pink), are positioned along the cytosolic and extracellular vestibules, with their side chains exposed to solvent. Different from the residues that directly coordinate chloride at Sfilter (Fig. 5A, yellow), the function of these arginine and lysine residues is to stabilize the partially hydrated anions through electrostatic interactions and to discriminate against cations. The side chains of Q98 and S341 also face the cytosolic vestibule to form anion–dipole interactions with chloride and contribute to ion selectivity. R334, positioned at the extracellular mouth of the pore, plays a dual role in forming the selectivity filter and attracting anions into the pore through electrostatic interactions. Many other functionally important residues, including P99, L102, I106, Y109, I336, S1118, and T1134 (Fig. 5A, cyan), do not directly interact with chloride. Instead, they form a second coordination sphere of Sfilter that likely contributes to structuring Sfilter residues with the appropriate geometry to coordinate chloride.
The ion coordination site in CFTR closely resembles one of the chloride-binding sites in the CLC chloride channels (84–87), sharing a similar amino acid composition (Fig. 5C). In CLCs, the dehydrated chloride at the Scen site is coordinated by positive helix dipoles, main-chain amides, aromatic side chains, and sidechain oxygen atoms of serine and tyrosine residues (84–87). As for T338 and Y914 of CFTR that form similar interactions in Sfilter, substitution of ion-coordinating serine and tyrosine residues in CLC affects ion selectivity, conductance, and open channel block (88, 89). In CLCs, no lysine nor arginine was involved in ion binding. In CFTR, although R334 is part of Sfilter, it interacts with the chloride ion through a weak long-range salt bridge. As discussed earlier by MacKinnon and colleagues (85), a strong Coulomb interaction at a selectivity filter may create a deep energy well and cause a chloride ion to bind too tightly to achieve high conduction rates. Thus, the structures of CFTR and CLCs demonstrate how unrelated ion channels have evolved to select and conduct chloride using common chemical strategies.
It has long been expected that in the fully conductive state, CFTR must exhibit a continuous, open passage across the lipid bilayer, with the narrowest dimensions larger than the permeating ion. Because a probe with radius equal to that of a dehydrated chloride ion cannot fully traverse the extracellular exit between TMs 1 and 6, the conformation of the E1371Q variant was previously interpreted to reflect the rapid flicker-closure events that occur within CFTR’s open burst (29, 40, 90, 91). The analysis presented in this work suggests that this notion should be revised. As previously discussed (84), ion channels do not necessarily require a wide pore. Ions can be conducted even when certain parts of the pore on average are marginally narrower than the ions themselves. This is feasible as long as the residues forming the pore possess electrostatic and chemical characteristics that support ion conduction and are flexible to facilitate ion diffusion. In potassium channels, for example, the pore radius between the potassium-binding sites in the selectivity filter is much smaller than that of a potassium ion, yet a conduction rate of 108 per second can be achieved in this configuration (92). Another example is the CLC-1 channel (84), in which the chloride-binding site is separated from the external solvent by a narrow constriction with a 1 Å radius, a configuration similar to that of the external mouth of CFTR. In CFTR, the ion at Sfilter is separated from the epithelial lumen through a small opening of 1.4 Å, slightly smaller than the 1.7 Å of a dehydrated chloride. Given the high open probability of the E1371Q variant and the understanding that thermal motions can transiently widen the exit constriction to allow ion passage, we suggest that the structure of the NBD-dimerized E1371Q variant actually reflects the conductive state of CFTR.
Methods
Cell Culture.
Sf9 cells (Gibco, catalog number 11496015, lot number 1670337) were grown at 27 °C in Sf-900 II SFM medium (Gibco) supplemented with 5% (v/v) heat-inactivated fetal bovine serum (FBS) and 1% (v/v) antibiotic-antimycotic (Gibco). HEK293S GnTI− suspension cells (the American Type Culture Collection (ATCC) CRL-3022, lot number 62430067) were cultured at 37 °C in Freestyle 293 medium (Gibco) supplemented with 2% (v/v) FBS and 1% (v/v) antibiotic-antimycotic. CHO-K1 cells (ATCC CCL-61, lot number 70014310) were cultured at 37 °C in Dulbecco’s Modified Eagle Medium (DMEM) F-12 medium (ATCC) supplemented with 10% (v/v) FBS and 1% (v/v) GlutaMAX (Gibco).
Protein Expression and Purification.
CFTR constructs were expressed and purified as previously described (93). Human CFTR with a C-terminal PreScission Protease-cleavable green fluorescent protein (GFP) tag was cloned into the BacMam vector. Recombinant baculovirus was generated using Sf9 cells as previously described (94). HEK293S GnTl- suspension cells, at a density of 2.5 × 106 cells/mL, were infected with 10% (v/v) P3 baculovirus. Protein expression was induced by adding 10 mM sodium butyrate to the culture 12 h after infection. The cells were cultured at 30 °C for an additional 48 h and then harvested.
For protein purification, cells were solubilized for 75 min at 4 °C in extraction buffer containing 1.25% (w/v) lauryl maltose neopentyl glycol (LMNG), 0.25% (w/v) cholesteryl hemisuccinate (CHS), 200 mM NaCl, 20 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) pH 7.2 (with NaOH), 2 mM MgCl2, 2 mM dithiothreitol (DTT), 20% (v/v) glycerol, 1 μg/mL pepstatin A, 1 μg/mL leupeptin, 1 μg/mL aprotinin, 100 μg/mL soy trypsin inhibitor, 1 mM benzamidine, 1 mM phenylmethylsulfonyl fluoride (PMSF), and 3 µg/mL DNase I.
Lysate was clarified by centrifugation at 75,000 g for 2 × 20 min at 4 °C and mixed with NHS-activated Sepharose 4 Fast Flow resin (GE Healthcare) conjugated with GFP nanobody, which had been pre-equilibrated in 20 column volumes of extraction buffer. After 1 h, the resin was packed into a chromatography column, washed with 20 column volumes of wash buffer containing 0.006% (w/v) glyco-diosgenin (GDN), 200 mM NaCl, 20 mM HEPES (pH 7.2 with NaOH), and 2 mM MgCl2 and then incubated for 2 h at 4 °C with 0.35 mg/mL PreScission Protease to cleave off the GFP tag. The eluate was collected by dripping through Glutathione Sepharose 4B resin (Cytiva) to remove PreScission Protease, concentrated, and phosphorylated with PKA (New England Biolabs) for 1 h at 20 °C. CFTR was purified by gel filtration chromatography at 4 °C using a Superose 6 10/300 GL column (GE Healthcare), equilibrated with 0.006% (w/v) GDN, 200 mM NaCl, 20 mM HEPES (pH 7.2 with NaOH) and 2 mM MgCl2.
Proteoliposome Reconstitution and Planar Bilayer Recording.
The lipids 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, 1-palmitoyl-2-oleyl-sn-glycero-3-phosphocholine, and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine were mixed at a 2:1:1 (w/w/w) ratio and resuspended by sonication in buffer containing 200 mM NaCl, 20 mM HEPES (pH 7.2 with NaOH), and 2 mM MgCl2 to a final lipid concentration of 20 mg/mL. Then, 2% (w/v) GDN was added and the mixture was incubated for 1 h at 25 °C. CFTR was mixed with the lipids at a protein-to-lipid ratio of 1:250 (w/w) and incubated at 4 °C for 2 h. Then, 14 mg/mL methylated beta-cyclodextrin was added to the mixture. After 4 h an equivalent amount of methylated beta-cyclodextrin was added to the mixture. This was performed for a total of four additions. Proteoliposomes were pelleted by centrifugation at 150,000 g for 45 min at 4 °C and resuspended in buffer containing 200 mM NaCl, 20 mM HEPES (pH 7.2 with NaOH), and 2 mM MgCl2.
Synthetic planar lipid bilayers were made from a lipid mixture containing 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, 1-palmitoyl-2-oleyl-sn-glycero-3-phosphocholine, and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine at a 2:1:1 (w/w/w) ratio. Proteoliposomes containing PKA-phosphorylated CFTR were fused with the bilayers. Currents were recorded at 25 °C in symmetric buffer containing 150 mM NaCl, 2 mM MgCl2, 20 mM HEPES (pH 7.2 with NaOH), and 3 mM ATP. Voltage was clamped with an Axopatch 200B amplifier (Molecular Devices). Currents were low-pass filtered at 1 kHz, digitized at 20 kHz with a Digidata 1440A digitizer, and recorded using the pCLAMP software suite (Molecular devices). Recordings were further low-pass filtered at 100 Hz. Data were analyzed with Clampfit and OriginPro.
Patch-Clamp Electrophysiology.
CHO-K1 cells were seeded in 35-mm cell culture dishes (Falcon) 24 h before transfection. Cells were transiently transfected with BacMam vector encoding C-terminally GFP-fused CFTR, using Lipofectamine 3000 (Invitrogen). Twelve hours after transfection, the medium was exchanged for DMEM-F12 supplemented with 2% (v/v) FBS and 1% (v/v) GlutaMAX and incubation temperature was reduced to 30 °C. Patch-clamp recording was carried out after an additional 24 h.
Recordings were carried out using the inside-out patch configuration with local perfusion at the patch. Recording pipettes were pulled from borosilicate glass (outer diameter 1.5 mm, inner diameter 0.86 mm, Sutter) to 1.5 to 3.0 MΩ resistance. Currents were recorded using an Axopatch 200B amplifier, a Digidata 1550 digitizer, and the pClamp software suite (Molecular Devices). Recordings were low-pass filtered at 1 kHz and digitized at 20 kHz.
For biionic potential measurements, currents were recorded during voltage steps from −80 to 80 mV from a holding potential of 0 mV. Pipette solution contained 150 mM NaCl, 2 mM MgSO4, and 10 mM HEPES (pH 7.4 with NaOH). Perfusion solutions contained 150 mM NaX, 2 mM MgSO4, and 10 mM HEPES (pH 7.4 with NaOH), where X = F, Cl, Br, I, or SCN. For measurements of SCN block, perfusion solution contained (1- xSCN) × 150 mM NaCl, xSCN × 150 mM NaSCN, 2 mM MgSO4, and 10 mM HEPES (pH 7.4 with NaOH), where xSCN is the mole fraction of monovalent anion that is SCN−. MgATP was added where indicated. The ground electrode was connected to the bath via a NaCl-containing agar salt-bridge. Relative permeabilities were calculated from reversal potentials using the Goldman–Hodgkin–Katz equation (74, 75). Reported potentials were corrected for liquid junction potentials. Liquid junction potentials were calculated using the stationary Nernst–Planck equation with LJPcalc (95).
For all measurements, CFTR was activated by exposure to PKA (Sigma-Aldrich) and 3 mM ATP. To ensure that each patch did not become leaky, voltage-families were collected in symmetric chloride without ATP before and after making biionic potential and SCN block measurements. Patches with substantial ATP-independent chloride conductance were excluded from analysis. Experiments were conducted at 25 °C. Displayed recordings were low-pass filtered at 100 Hz. Data were analyzed using Clampfit, GraphPad Prism, and OriginPro.
Fluorescent Size-Exclusion Chromatography.
Adherent HEK293S GnTI− cells were cultured at 37 °C in DMEM-F12 supplemented with 10% (v/v) FBS and 1% (v/v) GlutaMAX in 6-well CellBIND plates (Corning), to 90% confluency. Cells were transiently transfected with BacMam vector encoding C-terminally GFP-fused CFTR, using Lipofectamine 3000 (Invitrogen). Eight hours after transfection, the medium was exchanged for DMEM-F12 supplemented with 2% (v/v) FBS and 1% (v/v) GlutaMAX. Cells were cultured for an additional 24 h at 30 °C, collected by resuspension in Dulbecco’s phosphate-buffered saline (Gibco), pelleted by centrifugation, and snap-frozen in liquid nitrogen.
Cells were resuspended in extraction buffer containing 1.25% (w/v) LMNG, 0.25% (w/v) CHS, 200 mM NaCl, 20 mM HEPES (pH 7.2 with NaOH), 2 mM MgCl2, 2 mM DTT, 20% (v/v) glycerol, 1 μg/mL pepstatin A, 1 μg/mL leupeptin, 1 μg/mL aprotinin, 100 μg/mL soy trypsin inhibitor, 1 mM benzamidine, 1 mM PMSF and 3 µg/mL Dnase I, and incubated for 1 h at 4 °C. Clarified lysates were loaded onto a Superose 6 10/300 GL column (GE Healthcare), attached to an analytical high-performance liquid chromatography system with in-line fluorescence detection (Shimadzu). Fluorescence chromatograms were collected at λex = 488 nm and λem = 512 nm.
Supplementary Material
Acknowledgments
We thank members of the Chen and MacKinnon laboratories for helpful discussions, Dr. K. Fiedorczuk for sharing the cryo-EM map before publication, and Dr. L. Csanády for comments on the manuscript. This work was supported by the Howard Hughes Medical Institute (to J.C.).
Author contributions
J.L. and J.C. designed research; J.L. performed research; J.L. and J.C. analyzed data; and J.L. and J.C. wrote the paper.
Competing interests
The authors declare no competing interest.
Footnotes
This article is a PNAS Direct Submission.
Data, Materials, and Software Availability
All data and information are available in the main text or the SI Appendix.
Supporting Information
References
- 1.Anderson M. P., Welsh M. J., Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains. Science 257, 1701–1704 (1992). [DOI] [PubMed] [Google Scholar]
- 2.Berger H. A., et al. , Identification and regulation of the cystic fibrosis transmembrane conductance regulator-generated chloride channel. J. Clin. Invest. 88, 1422–1431 (1991). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Cheng S. H., et al. , Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. Cell 66, 1027–1036 (1991). [DOI] [PubMed] [Google Scholar]
- 4.Tabcharani J. A., Chang X.-B., Riordan J. R., Hanrahan J. W., Phosphorylation-regulated CI− channel in CHO cells stably expressing the cystic fibrosis gene. Nature 352, 628–631 (1991). [DOI] [PubMed] [Google Scholar]
- 5.Picciotto M. R., Cohn J. A., Bertuzzi G., Greengard P., Nairn A. C., Phosphorylation of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 267, 12742–12752 (1992). [PubMed] [Google Scholar]
- 6.Csanády L., Vergani P., Gadsby D. C., Strict coupling between CFTR’s catalytic cycle and gating of its Cl− ion pore revealed by distributions of open channel burst durations. Proc. Natl. Acad. Sci. U.S.A. 107, 1241–1246 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Cutting G. R., Cystic fibrosis genetics: From molecular understanding to clinical application. Nat. Rev. Genet. 16, 45–56 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Riordan J. R., et al. , Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245, 1066–1073 (1989). [DOI] [PubMed] [Google Scholar]
- 9.Rommens J. M., et al. , Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 245, 1059–1065 (1989). [DOI] [PubMed] [Google Scholar]
- 10.Quinton P. M., Bijman J., Higher bioelectric potentials due to decreased chloride absorption in the sweat glands of patients with cystic fibrosis. N. Engl. J. Med. 308, 1185–1189 (1983). [DOI] [PubMed] [Google Scholar]
- 11.Widdicombe J. H., Welsh M. J., Finkbeiner W. E., Cystic fibrosis decreases the apical membrane chloride permeability of monolayers cultured from cells of tracheal epithelium. Proc. Natl. Acad. Sci. U.S.A. 82, 6167–6171 (1985). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Shah V. S., et al. , Relationships among CFTR expression, HCO3− secretion, and host defense may inform gene- and cell-based cystic fibrosis therapies. Proc. Natl. Acad. Sci. U.S.A. 113, 5382–5387 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Wang Y., Wrennall J. A., Cai Z., Li H., Sheppard D. N., Understanding how cystic fibrosis mutations disrupt CFTR function: From single molecules to animal models. Int. J. Biochem. Cell Biol. 52, 47–57 (2014). [DOI] [PubMed] [Google Scholar]
- 14.The Clinical and Functional TRanslation of CFTR (CFTR2). https://www.cftr2.org/mutations_history. Accessed 28 July 2023.
- 15.A. C. Chao, et al. , Activation of intestinal CFTR Cl- channel by heat-stable enterotoxin and guanylin via cAMP-dependent protein kinase. EMBO J. 13, 1065–1072 (1994). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Torres V. E., Harris P. C., Strategies targeting cAMP signaling in the treatment of polycystic kidney disease. J. Am. Soc. Nephrol. 25, 18 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Harris J. B., LaRocque R. C., Qadri F., Ryan E. T., Calderwood S. B., Cholera. The Lancet 379, 2466–2476 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Patel V., Chowdhury R., Igarashi P., Advances in the pathogenesis and treatment of polycystic kidney disease. Curr. Opin. Nephrol. Hypertension 18, 99 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Csanády L., Vergani P., Gadsby D. C., Structure, Gating, and Regulation of the CFTR Anion Channel. Physiol. Rev. 99, 707–738 (2019). [DOI] [PubMed] [Google Scholar]
- 20.Hwang T.-C., et al. , Structural mechanisms of CFTR function and dysfunction. J. Gen. Physiol. 150, 539–570 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Hadida S., et al. , Discovery of N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, Ivacaftor), a Potent and Orally Bioavailable CFTR Potentiator. J. Med. Chem. 57, 9776–9795 (2014). [DOI] [PubMed] [Google Scholar]
- 22.Keating D., et al. , VX-445–Tezacaftor–ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles. N. Engl. J. Med. 379, 1612–1620 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Ramsey B. W., et al. , A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N. Engl. J. Med. 365, 1663–1672 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Wainwright C. E., et al. , Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR. N. Engl. J. Med. 373, 220–231 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Taylor-Cousar J. L., et al. , Tezacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del. N. Engl. J. Med. 377, 2013–2023 (2017). [DOI] [PubMed] [Google Scholar]
- 26.Van der Plas S. E., et al. , Discovery of N-(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-lH-pyrazole-5-carboxamide (GLPG1837), a novel potentiator which can open class III mutant cystic fibrosis transmembrane conductance regulator (CFTR) channels to a high extent. J. Med. Chem. 61, 1425–1435 (2018). [DOI] [PubMed] [Google Scholar]
- 27.Ma T., et al. , Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin–induced intestinal fluid secretion. J. Clin. Invest. 110, 1651–1658 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Seibert F. S., et al. , Influence of phosphorylation by protein kinase A on CFTR at the cell surface and endoplasmic reticulum. Biochim. Biophys. Acta 1461, 275–283 (1999). [DOI] [PubMed] [Google Scholar]
- 29.Zhang Z., Liu F., Chen J., Conformational changes of CFTR upon phosphorylation and ATP binding. Cell 170, 483–491.e8 (2017). [DOI] [PubMed] [Google Scholar]
- 30.Levring J., et al. , CFTR function, pathology and pharmacology at single-molecule resolution. Nature 616, 606–614 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Vergani P., Lockless S. W., Nairn A. C., Gadsby D. C., CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains. Nature 433, 876–880 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Jardetzky O., Simple allosteric model for membrane pumps. Nature 211, 969–970 (1966). [DOI] [PubMed] [Google Scholar]
- 33.Oldham M. L., Davidson A. L., Chen J., Structural insights into ABC transporter mechanism. Curr. Opin. Struct. Biol. 18, 726–733 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Locher K. P., Structure and mechanism of ATP-binding cassette transporters. Phil. Trans. R. Soc. B Biol. Sci. 364, 239–245 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Dawson R. J. P., Locher K. P., Structure of a bacterial multidrug ABC transporter. Nature 443, 180–185 (2006). [DOI] [PubMed] [Google Scholar]
- 36.Johnson Z. L., Chen J., ATP Binding Enables Substrate Release from Multidrug Resistance Protein 1. Cell 172, 81–89.e10 (2018). [DOI] [PubMed] [Google Scholar]
- 37.Kim Y., Chen J., Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation. Science 359, 915–919 (2018). [DOI] [PubMed] [Google Scholar]
- 38.El Hiani Y., Linsdell P., Functional architecture of the cytoplasmic entrance to the cystic fibrosis transmembrane conductance regulator chloride channel pore*. J. Biol. Chem. 290, 15855–15865 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.El Hiani Y., Negoda A., Linsdell P., Cytoplasmic pathway followed by chloride ions to enter the CFTR channel pore. Cell. Mol. Life Sci. 73, 1917–1925 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Zhang Z., Liu F., Chen J., Molecular structure of the ATP-bound, phosphorylated human CFTR. Proc. Natl. Acad. Sci. U.S.A. 115, 12757–12762 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Linsdell P., Architecture and functional properties of the CFTR channel pore. Cell. Mol. Life Sci. 74, 67–83 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Linsdell P., Hanrahan J. W., Disulphonic stilbene block of cystic fibrosis transmembrane conductance regulator Cl- channels expressed in a mammalian cell line and its regulation by a critical pore residue. J. Physiol. 496, 687–693 (1996). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Sheppard D. N., Robinson K. A., Mechanism of glibenclamide inhibition of cystic fibrosis transmembrane conductance regulator Cl−channels expressed in a murine cell line. J. Physiol. 503, 333–346 (1997). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Bai Y., Li M., Hwang T.-C., Structural basis for the channel function of a degraded ABC transporter, CFTR (ABCC7). J. Gen. Physiol. 138, 495–507 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.St Aubin C. N., Zhou J.-J., Linsdell P., Identification of a second blocker binding site at the cytoplasmic mouth of the cystic fibrosis transmembrane conductance regulator chloride channel pore. Mol. Pharmacol. 71, 1360–1368 (2007). [DOI] [PubMed] [Google Scholar]
- 46.Zhou Z., Hu S., Hwang T.-C., Probing an open CFTR pore with organic anion blockers. J. Gen. Physiol. 120, 647–662 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Liu F., et al. , Structural identification of a hotspot on CFTR for potentiation. Science 364, 1184–1188 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Fiedorczuk K., Chen J., Mechanism of CFTR correction by type I folding correctors. Cell 185, 158–168.e11 (2022). [DOI] [PubMed] [Google Scholar]
- 49.Fiedorczuk K., Chen J., Molecular structures reveal synergistic rescue of Δ508 CFTR by Trikafta modulators. Science 378, 284–290 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Anderson M. P., et al. , Demonstration That CFTR is a chloride channel by alteration of its anion selectivity. Science 253, 202–205 (1991). [DOI] [PubMed] [Google Scholar]
- 51.Sheppard D. N., et al. , Mutations in CFTR associated with mild-disease-form CI- channels with altered pore properties. Nature 362, 160–164 (1993). [DOI] [PubMed] [Google Scholar]
- 52.Tabcharani J. A., et al. , Multi-ion pore behaviour in the CFTR chloride channel. Nature 366, 79–82 (1993). [DOI] [PubMed] [Google Scholar]
- 53.McDonough S., Davidson N., Lester H. A., McCarty N. A., Novel pore-lining residues in CFTR that govern permeation and open-channel block. Neuron 13, 623–634 (1994). [DOI] [PubMed] [Google Scholar]
- 54.Gao X., Bai Y., Hwang T.-C., Cysteine scanning of CFTR’s First transmembrane segment reveals its plausible roles in gating and permeation. Biophys. J. 104, 786–797 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Fatehi M., Linsdell P., Novel residues lining the CFTR chloride channel pore identified by functional modification of introduced cysteines. J. Membrane Biol. 228, 151–164 (2009). [DOI] [PubMed] [Google Scholar]
- 56.Smith S. S., et al. , Cftr: Covalent and noncovalent modification suggests a role for fixed charges in anion conduction. J. Gen. Physiol. 118, 407–432 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Zeng Z. W., Linsdell P., Pomès R., Molecular dynamics study of Cl− permeation through cystic fibrosis transmembrane conductance regulator (CFTR). Cell. Mol. Life Sci. 80, 51 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Carugo O., Buried chloride stereochemistry in the Protein Data Bank. BMC Struct. Biol. 14, 19 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Jackson M. R., et al. , A preference for edgewise interactions between aromatic rings and carboxylate anions: The biological relevance of anion−quadrupole interactions. J. Phys. Chem. B 111, 8242–8249 (2007). [DOI] [PubMed] [Google Scholar]
- 60.Hofmann S., et al. , Conformation space of a heterodimeric ABC exporter under turnover conditions. Nature 571, 580–583 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Johnson Z. L., Chen J., Structural basis of substrate recognition by the multidrug resistance protein MRP1. Cell 168, 1075–1085.e9 (2017). [DOI] [PubMed] [Google Scholar]
- 62.Wang J., et al. , Placing steroid hormones within the human ABCC3 transporter reveals a compatible amphiphilic substrate-binding pocket. EMBO J. 42, e113415 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Bloch M., Raj I., Pape T., Taylor N. M. I., Structural and mechanistic basis of substrate transport by the multidrug transporter MRP4. Structure 31, 1407–1418.e6 (2023). [DOI] [PubMed] [Google Scholar]
- 64.Negoda A., Hogan M. S., Cowley E. A., Linsdell P., Contribution of the eighth transmembrane segment to the function of the CFTR chloride channel pore. Cell. Mol. Life Sci. 76, 2411–2423 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Gong X., Burbridge S. M., Cowley E. A., Linsdell P., Molecular determinants of Au(CN)2− binding and permeability within the cystic fibrosis transmembrane conductance regulator Cl− channel pore. J. Physiol. 540, 39–47 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Linsdell P., Relationship between anion binding and anion permeability revealed by mutagenesis within the cystic fibrosis transmembrane conductance regulator chloride channel pore. J. Physiol. 531, 51–66 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Linsdell P., Evagelidis A., Hanrahan J. W., Molecular determinants of anion selectivity in the cystic fibrosis transmembrane conductance regulator chloride channel pore. Biophys. J. 78, 2973–2982 (2000). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Gupta J., Linsdell P., Extent of the selectivity filter conferred by the sixth transmembrane region in the CFTR chloride channel pore. Mol. Membrane Biol. 20, 45–52 (2003). [DOI] [PubMed] [Google Scholar]
- 69.Gao X., Hwang T.-C., Localizing a gate in CFTR. Proc. Natl. Acad. Sci. U.S.A. 112, 2461–2466 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Cheung M., Akabas M. H., Locating the anion-selectivity filter of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. J. Gen. Physiol. 109, 289–299 (1997). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Negoda A., El Hiani Y., Cowley E. A., Linsdell P., Contribution of a leucine residue in the first transmembrane segment to the selectivity filter region in the CFTR chloride channel. Biochim. Biophys. Acta 1859, 1049–1058 (2017). [DOI] [PubMed] [Google Scholar]
- 72.Leoni G. B., et al. , A specific cystic fibrosis mutation (T338I) associated with the phenotype of isolated hypotonic dehydration. J. Pediatrics 127, 281–283 (1995). [DOI] [PubMed] [Google Scholar]
- 73.Linsdell P., Zheng S.-X., Hanrahan J. W., Non-pore lining amino acid side chains influence anion selectivity of the human CFTR Cl− channel expressed in mammalian cell lines. J. Physiol. 512, 1–16 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Goldman D. E., Potential, impedance, and rectification in membranes. J. Gen. Physiol. 27, 37–60 (1943). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Hodgkin A. L., Katz B., The effect of sodium ions on the electrical activity of the giant axon of the squid. J. Physiol. 108, 37–77 (1949). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Smith S. S., Steinle E. D., Meyerhoff M. E., Dawson D. C., Cystic fibrosis transmembrane conductance regulator: Physical basis for lyotropic anion selectivity patterns. J. Gen. Physiol. 114, 799–818 (1999). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Smith D. W., Ionic hydration enthalpies. J. Chem. Educ. 54, 540 (1977). [Google Scholar]
- 78.Mansoura M. K., et al. , Cystic fibrosis transmembrane conductance regulator (CFTR) anion binding as a probe of the pore. Biophys. J. 74, 1320–1332 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Zhou Z., Hu S., Hwang T.-C., Voltage-dependent flickery block of an open cystic fibrosis transmembrane conductance regulator (CFTR) channel pore. J. Physiol. 532, 435–448 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Dutzler R., Campbell E. B., MacKinnon R., Gating the selectivity filter in ClC chloride channels. Science 300, 108–112 (2003). [DOI] [PubMed] [Google Scholar]
- 81.Ge N., Muise C. N., Gong X., Linsdell P., Direct comparison of the functional roles played by different transmembrane regions in the cystic fibrosis transmembrane conductance regulator chloride channel pore*. J. Biol. Chem. 279, 55283–55289 (2004). [DOI] [PubMed] [Google Scholar]
- 82.Zhou J.-J., Fatehi M., Linsdell P., Identification of positive charges situated at the outer mouth of the CFTR chloride channel pore. Pflugers Arch. 457, 351–360 (2008). [DOI] [PubMed] [Google Scholar]
- 83.C. N. St. Aubin, P. Linsdell, Positive charges at the intracellular mouth of the pore regulate anion conduction in the CFTR chloride channel. J. Gen. Physiol. 128, 535–545 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Park E., MacKinnon R., Structure of the CLC-1 chloride channel from Homo sapiens. eLife 7, e36629 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Dutzler R., Campbell E. B., Cadene M., Chait B. T., MacKinnon R., X-ray structure of a ClC chloride channel at 3.0 Å reveals the molecular basis of anion selectivity. Nature 415, 287–294 (2002). [DOI] [PubMed] [Google Scholar]
- 86.Park E., Campbell E. B., MacKinnon R., Structure of a CLC chloride ion channel by cryo-electron microscopy. Nature 541, 500–505 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Feng L., Campbell E. B., MacKinnon R., Molecular mechanism of proton transport in CLC Cl-/H+ exchange transporters. Proc. Natl. Acad. Sci. U.S.A. 109, 11699–11704 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Ludewig U., Pusch M., Jentsch T. J., Two physically distinct pores in the dimeric CIC-0 chloride channel. Nature 383, 340–343 (1996). [DOI] [PubMed] [Google Scholar]
- 89.Accardi A., Pusch M., Conformational changes in the pore of CLC-0. J. Gen. Physiol. 122, 277–293 (2003). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Gray M. A., Harris A., Coleman L., Greenwell J. R., Argent B. E., Two types of chloride channel on duct cells cultured from human fetal pancreas. Am. J. Physiol. Cell Physiol. 257, C240–C251 (1989). [DOI] [PubMed] [Google Scholar]
- 91.Fischer H., Machen T. E., CFTR displays voltage dependence and two gating modes during stimulation. J. Gen. Physiol. 104, 541–566 (1994). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Zhou Y., Morais-Cabral J. H., Kaufman A., MacKinnon R., Chemistry of ion coordination and hydration revealed by a K+ channel–Fab complex at 2.0 Å resolution. Nature 414, 43–48 (2001). [DOI] [PubMed] [Google Scholar]
- 93.Zhang Z., Chen J., Atomic structure of the cystic fibrosis transmembrane conductance regulator. Cell 167, 1586–1597.e9 (2016). [DOI] [PubMed] [Google Scholar]
- 94.Goehring A., et al. , Screening and large-scale expression of membrane proteins in mammalian cells for structural studies. Nat. Protoc. 9, 2574–2585 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Marino M., Misuri L., Brogioli D., A new open source software for the calculation of the liquid junction potential between two solutions according to the stationary Nernst-Planck equation. arXiv [Preprint] (2014). 10.48550/arXiv.1403.3640 (Accessed 27 July 2023). [DOI]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data and information are available in the main text or the SI Appendix.